Viral Vitalism

Age Reversal Progress Map

Cellular senescence

Senolytics, senomorphics, and immune clearance strategies aimed at senescent-cell burden and inflammatory signaling.

<- Full mapProof of concept

Current row read

Editorial placement: Proof of concept

Graph-derived stage: Proof of concept

Foundational science
Proof of concept
Early human evidence
Clinical traction
Human signal
62/100
Confidence
41/100
Evidence purity
78/100
Frontier watch
low
Bottleneck
evidence maturity
Proof of conceptEditorial placement

Current read

Editorial placement: Proof of concept

Graph-derived stage: Proof of concept

Override reason: Senescence is a foundational aging-biology lane, but current VV graph support is still mostly mechanism and adjacent inflammation evidence.

Proof of concept from 2 study records, 2 active source records, 0 rapid briefs, and 0 timeline events. Evidence maturity is 15/100, human translation signal is 62/100, and frontier activity is low (5/100). Frontier activity means research movement, not settled human proof. Editorial placement shown publicly: Proof of concept. Graph-derived stage: Proof of concept. Override note: Senescence is a foundational aging-biology lane, but current VV graph support is still mostly mechanism and adjacent inflammation evidence.

This lane has plausible intervention signals but is not mature human evidence.

Evidence maturity15/100
Source quality90/100
Human translation11/100
Human translation signal62/100
Update velocity33/100
Safety boundary45/100
Frontier activity5/100
Evidence purity78/100

Commercial bias penalty: 0/100. Confidence: 41/100. Frontier activity means research movement, not settled human proof.

Why this row matters

Senolytics, senomorphics, and immune clearance strategies aimed at senescent-cell burden and inflammatory signaling. The map tracks whether this lane is moving from biological plausibility toward outcomes people can responsibly discuss.

Current human translation

Human translation is 11/100 based on human-facing studies, clinical/regulatory sources, claims, and published coverage.

Main approaches being tracked

Senolytics, senomorphic drugs, immune-mediated clearance.

What would move this row up?

Current bottleneck

evidence maturity, safety boundaries

Milestones that would move this row up

Human trials showing meaningful function, frailty, fibrosis, or disease-endpoint improvement
Better senescent-cell burden diagnostics
Independent replication with safety monitoring

Row movement

Mini timeline

Newest graph events across studies, sources, briefs, claims, and timeline records

Open evidence gaps

These gaps are matched from the evidence-gap ledger where possible, with row-level placeholders used when the graph is not yet enriched.

openmedium

Human trials showing functional, frailty, fibrosis, or disease-endpoint improvement from senescence-targeted interventions.

Human trials showing functional, frailty, fibrosis, or disease-endpoint improvement from senescence-targeted interventions.

openmedium

Validated senescent-cell burden diagnostics linked to outcomes.

Validated senescent-cell burden diagnostics linked to outcomes.

Evidence that would change the map

  • Raise evidence maturity from 15/100 with better controlled studies or stronger replication.
  • Raise human translation from 11/100 with outcomes that matter in people, not only biomarkers or mechanisms.
  • Preserve safety discipline with clearer limitations, contraindications, and overclaim boundaries as activity grows.

What not to overclaim

  • Do not claim clearing senescent cells broadly reverses aging in humans.
  • Do not treat animal lifespan signals as consumer-ready therapy.

Research map

Related studies

Study records matched through topic tags, intervention IDs, source IDs, related content, or row-specific tags.

No structured study records are attached to this row yet.

Useful source library entries

Related published coverage

Published coverage contributes to coverage depth, not evidence maturity by itself.

NutritionEmerging evidenceSeed Oils

Seed Oils: Toxic Sludge or Internet Scapegoat?

Seed oils are blamed for inflammation, obesity, heart disease, and metabolic collapse. The stronger signal is not that linoleic-acid-rich oils are toxic. It is that they often travel inside ultra-processed food patterns.

VV Signal Score

55

Early or context-dependent

Sources
7
Studies
6
Claims
10
AHA Dietary Fats AdvisoryAHA Omega-6 AdvisoryCochrane Omega-6 CVD Review
13 min readRead->
LongevityEmerging evidenceSleep

Sleep Is More Than Hours—and Less Certain Than the Headlines

Poor sleep tracks with inflammation, chronic disease, and mortality risk. The signal is meaningful, but the strongest outcome evidence is observational—not proof that a better sleep score adds years to life.

VV Signal Score

65

Promising signal

Sources
6
Studies
6
Claims
6
All of Us Wearable SleepCDC Sleep GuidanceSleep and Inflammation Review
13 min readRead->

Claim ledger

Related claims

Claim ledger records matched by topic, intervention, study, or source links.

Related topics

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No selling your information. Unsubscribe anytime.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.